Drug Profile
ML 009723
Latest Information Update: 21 Jan 1997
Price :
$50
*
At a glance
- Originator Unknown
- Developer Merckle
- Class Anticoagulants; Antithrombotics; Low molecular weight heparins
- Mechanism of Action Thrombin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Thrombosis
Most Recent Events
- 21 Jan 1997 Investigation in Thrombosis in Germany (Unknown route)
- 15 Oct 1996 Preclinical development for Thrombosis in Germany (Unknown route)